Skip to main content
Caplight Logo









iUVeda

iUVeda

Private
—Healthcare & Life Scienceshttps://iuveda.io

Last Round

Series C

Mar 8, 2024

Total Funding Raised

$38.1M

Company Overview

iUVeda operates in Healthcare & Life Sciences. Its latest recorded funding round was a Series C round in March 2024.

iUVeda is a health and wellness company that provides an AI-driven mobile application offering personalized yoga, meditation, and nutrition guidance based on Ayurvedic principles.

Sector

Healthcare & Life Sciences

Verticals

NLP & Conversational AI, Home & Lifestyle

Business Model

B2C

Customer Profile

Freemium, Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

iUVeda Comparables

Compare iUVeda with similar companies based on industry and business-model similarity.

iUVeda comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NBADVISORY
85%
CureNatural
80%
AyuRythm
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

iUVeda Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMar 8, 2024
Series BDec 20, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Rajashri Mohite

Founder & CEO

Founding Team

For institutional investors. Book with your work email.

iUVeda Investors

Notable investors and investment history

iUVeda investors
InvestorRounds
Riverwalk HoldingsSeries B
Kalpavriksh FundSeries A
Sharrp VenturesSeries B, Series C
Fireside VenturesSeries A
SIDBI Venture CapitalSeries C
Singularity GrowthSeries B
Anicut CapitalSeries C, Series B
Book a demo to see all 8 investors

For institutional investors. Book with your work email.

iUVeda Filings

Explore SEC and related filing metadata, where available.

iUVeda filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about iUVeda's valuation, stock price, and market status.

Is iUVeda a public or private company?

iUVeda is a private company.

What is the current stock price of iUVeda?

iUVeda is a private company, so its shares have no public market price. Caplight tracks iUVeda's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is iUVeda worth (valuation)?

Valuation information for iUVeda is not publicly available.

Can I buy iUVeda stock?

iUVeda shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was iUVeda's last funding round?

iUVeda's most recent funding round was Series C on March 8, 2024.

Who are the main investors in iUVeda?

Key investors in iUVeda include Anicut Capital, Jungle Ventures.

Will iUVeda IPO soon?

No public IPO plans have been announced for iUVeda.

How can I track iUVeda secondary market activity?

Caplight tracks bids, offers, and trades in iUVeda's shares on secondary markets.

Firmographic Details

Headquarters—
Employee Range1
Year Founded2018
Last FundingMar 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?